Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Gastroenterology
Published in: Indian Journal of Gastroenterology 6/2012

01-12-2012 | Editorial

National consensus on inflammatory bowel disease in India—an initiator’s perspective

Author: Gourdas Choudhuri

Published in: Indian Journal of Gastroenterology | Issue 6/2012

Login to get access

Excerpt

The publication in this issue of the Journal of national data on inflammatory bowel disease (IBD) and guidelines drawn by Indian experts on how to manage it in the subcontinent [1, 2], given our unique settings and challenges, marks a milestone in the efforts of the gastroenterology community of this country to confront and recognize this disease that we all now commonly encounter in practice, but have in the past shied away from examining comprehensively. …
Literature
1.
Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–8.PubMed
2.
Bhatia SJ, Reddy DN, Ghoshal UC, et al. Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2011;30:118–27.PubMedCrossRef
3.
Makharia GK, Ramakrishna BS, Abraham P, et al. for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012;31. doi:10.​1007/​s12664-012-0258-1.
4.
Ramakrishna BS, Makharia GK, Abraham P, et al. for Indian Society of Gastroenterology Task Force on Inflammatory Bowel Diseases. Indian Society of Gastroenterology consensus on ulcerative colitis. Indian J Gastroenterol. 2012;31. doi:10.​1007/​s12664-012-0259-0.
Metadata
Title
National consensus on inflammatory bowel disease in India—an initiator’s perspective
Author
Gourdas Choudhuri
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Indian Journal of Gastroenterology / Issue 6/2012
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-012-0266-1

Other articles of this Issue 6/2012

Indian Journal of Gastroenterology 6/2012 Go to the issue

Editorial

Inflammatory bowel disease: the Indian augury

TASK FORCE REPORT

Indian Society of Gastroenterology consensus on ulcerative colitis

Image

Pseudolesion in a patient with superior vena cava syndrome

Letter

Hepatitis B and C co-infection in HIV patients

Image

Intestinal lipomatosis detected on CT

Case Series

Intractable ascites as a manifestation of Wolman’s disease: report of two sibs
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits